STOCKHOLDERS' EQUITY |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||
| STOCKHOLDERS' EQUITY | STOCKHOLDERS’ EQUITY During the three months ended September 30, 2026 and 2025, the Company awarded stock grants totaling 11,727 and 32,197 shares, 11,727 and 19,197 of which were vested on the date of the award. In addition, on July 10, 2026, the Company completed an offering and sale of 2,374,356 shares of its common stock, par value $0.001 per share, pursuant to Regulation S of the Securities Act of 1933.
During the six months ended September 30, 2026 and 2025, the Company awarded stock grants totaling 147,906 and 243,888 shares, 123,606 and 119,126 of which were vested on the date of the award, respectively.
The table below presents Stock Incentive Plan awards granted on the dates indicated.
|
||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|